Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

TMC Stock News and Forecast: NOAA Seabed-Mining Permit Timeline Fuels Fresh Volatility for The Metals Company (NASDAQ:TMC)

TMC Stock News and Forecast: NOAA Seabed-Mining Permit Timeline Fuels Fresh Volatility for The Metals Company (NASDAQ:TMC)

Dec. 22, 2025 — TMC stock is back in the spotlight after a burst of options-driven momentum collided with a very real regulatory calendar: the U.S. government has now formally moved forward with public-comment steps tied to TMC USA’s deep seabed mining exploration license applications, setting up a catalyst-heavy start to 2026. Federal Register Public Inspection+2Federal Register Public Inspection+2
22 December 2025
··
Strive Asset Management (ASST) Stock News Today: SATA Dividend Hike, $500M ATM Program, and Fresh Index Risk as MSCI Debate Intensifies

Strive Asset Management (ASST) Stock News Today: SATA Dividend Hike, $500M ATM Program, and Fresh Index Risk as MSCI Debate Intensifies

Strive Asset Management, LLC is best known to public-market investors through its parent company, Strive, Inc., whose securities trade on Nasdaq as ASST and SATA. As of Dec. 22, 2025, Strive is back on the radar for a very 2025 reason: it sits at the intersection of traditional asset management and the bitcoin-treasury trade—a strategy that’s now facing new scrutiny from index providers and investors alike. investors.strive.com+1
22 December 2025
···
ProPhase Labs (PRPH) Stock News: Reverse Merger LOI With ABL, 1-for-10 Reverse Split Takes Effect Dec. 22, 2025

ProPhase Labs (PRPH) Stock News: Reverse Merger LOI With ABL, 1-for-10 Reverse Split Takes Effect Dec. 22, 2025

Dec. 22, 2025 — ProPhase Labs, Inc. is hitting one of the most consequential “inflection points” a micro-cap stock can face: a Nasdaq compliance deadline, a reverse stock split that reshapes how the ticker trades, and a newly announced non-binding reverse merger proposal that could dramatically change what ProPhase Labs is going forward. Reuters+3NASDAQ Trader+3ProPhase Labs, Inc.+3
22 December 2025
··
Planet Labs PBC (PL) Stock Today: December 22, 2025 News, Forecasts, and Analyst Takeaways After the Rally

Planet Labs PBC (PL) Stock Today: December 22, 2025 News, Forecasts, and Analyst Takeaways After the Rally

Planet Labs PBC is starting December 22, 2025 near record territory after a month of headline catalysts that blended three powerful themes investors can’t resist: defense demand, AI-enabled data, and improving financial momentum. In premarket trading, PL was quoted around $19.79 early Monday, after a $19.18 prior close—levels that keep the stock close to recent highs and firmly on traders’ radar. MarketWatch+1
22 December 2025
·
Barrick Mining Corporation Stock (NYSE: B, TSX: ABX) in Focus as Gold Breaks $4,400: Mali Restart, IPO Review, and 2026 Outlook (22.12.2025)

Barrick Mining Corporation Stock (NYSE: B, TSX: ABX) in Focus as Gold Breaks $4,400: Mali Restart, IPO Review, and 2026 Outlook (22.12.2025)

December 22, 2025 — Barrick Mining Corporation stock is ending the year with a rare triple tailwind: a fresh record in gold prices, a major geopolitical overhang easing in Mali, and an ongoing strategic shake-up that could materially change how the market values the company’s North American assets.
22 December 2025
···
Bitfarms Stock (BITF) in Focus on Dec. 22, 2025: S&P/TSX Composite Addition, AI Data Center Pivot, and Updated Analyst Forecasts

Bitfarms Stock (BITF) in Focus on Dec. 22, 2025: S&P/TSX Composite Addition, AI Data Center Pivot, and Updated Analyst Forecasts

December 22, 2025 — Bitfarms Ltd. is starting the week with a rare “three-engine” narrative that can move a stock fast: a major Canadian index inclusion, a high-profile strategic pivot from pure Bitcoin mining toward HPC/AI infrastructure, and a fresh round of forecast revisions from analysts tracking the company’s post-earnings trajectory. FT Markets+2S&P Global+2
22 December 2025
···
Redwire (RDW) Stock News Today: European Nyx Docking Deal, DARPA VLEO Catalyst, and Analyst Price Targets (Dec. 22, 2025)

Redwire (RDW) Stock News Today: European Nyx Docking Deal, DARPA VLEO Catalyst, and Analyst Price Targets (Dec. 22, 2025)

Redwire Corporation is back in the spotlight heading into the week of December 22, 2025, after a sharp two-day rally late last week and fresh commentary from analysts and market-watchers. The immediate spark: an eight-figure European spacecraft docking contract tied to The Exploration Company’s Nyx capsule program—news that has revived the “space infrastructure” narrative around Redwire at a time when investors are still weighing execution risk and cash burn across the broader space-and-defense supplier ecosystem. Redwire Corporation+2Investing.com+2
22 December 2025
··
fuboTV Inc. (FUBO) Stock News Today: Disney-Hulu Integration, NBCUniversal Blackout Fallout, and Analyst Price Targets on December 22, 2025

fuboTV Inc. (FUBO) Stock News Today: Disney-Hulu Integration, NBCUniversal Blackout Fallout, and Analyst Price Targets on December 22, 2025

fuboTV Inc. heads into the final stretch of 2025 as a very different company than it was a year ago—and the stock is trading like it. As of December 22, 2025, FUBO shares were around $2.71, reflecting a small rebound after a rocky late-November to mid-December stretch that’s been dominated by a high-stakes distribution fight with NBCUniversal and the messy reality of operating a “new” pay-TV giant under Disney’s controlling ownership.
22 December 2025
·
Amicus Therapeutics (FOLD) Stock on Dec. 22, 2025: BioMarin’s $14.50 Buyout, Latest News, Analyst Forecasts, and What’s Next

Amicus Therapeutics (FOLD) Stock on Dec. 22, 2025: BioMarin’s $14.50 Buyout, Latest News, Analyst Forecasts, and What’s Next

Dec. 22, 2025 — Amicus Therapeutics, Inc. has abruptly shifted from a “rare-disease growth story” into a deal-driven stock, after BioMarin Pharmaceutical announced an all-cash agreement to acquire Amicus for $14.50 per share. With shares trading around $14.18 on Dec. 22, the market is now pricing FOLD mostly on closing probability and timing, not clinical catalysts. Investing.com+1
22 December 2025
··
AST SpaceMobile (ASTS) Stock in Focus: BlueBird-6 Launch Countdown, Fresh Valuation Debate, and Wall Street Targets (Dec. 22, 2025)

AST SpaceMobile (ASTS) Stock in Focus: BlueBird-6 Launch Countdown, Fresh Valuation Debate, and Wall Street Targets (Dec. 22, 2025)

AST SpaceMobile, Inc. is back in the market’s spotlight on December 22, 2025, with investors zeroed in on one near-term catalyst: the launch of BlueBird 6, the company’s first next‑generation “Block 2” satellite. Today’s conversation around ASTS stock is a familiar mix of space-tech optimism, execution anxiety, and price action that can move faster than a rocket launch schedule.
22 December 2025
·
Datavault AI (DVLT) Stock News Today: New Blockchain Patents, 2026 Revenue Forecasts, and the Catalysts Moving Shares (Dec. 22, 2025)

Datavault AI (DVLT) Stock News Today: New Blockchain Patents, 2026 Revenue Forecasts, and the Catalysts Moving Shares (Dec. 22, 2025)

Datavault AI Inc. is back in the spotlight on December 22, 2025 after announcing two newly issued U.S. patents tied to blockchain-driven content licensing and tokenized monetization—an intellectual-property update that fits squarely into the company’s larger pitch: turning “real-world assets” and digital content into trackable, licensable, monetizable data objects. GlobeNewswire
22 December 2025
···
Sidus Space (SIDU) Stock News Today: Why Shares Are Jumping on Dec. 22, 2025 — Latest Catalysts, Financials, and Forecasts

Sidus Space (SIDU) Stock News Today: Why Shares Are Jumping on Dec. 22, 2025 — Latest Catalysts, Financials, and Forecasts

Sidus Space, Inc. is back on momentum traders’ radar to start the week. After closing at $1.16 on Friday, Dec. 19, 2025 on roughly 20.4 million shares traded, the stock was quoted around $1.40 in pre-market trading on Monday, Dec. 22—a notable move for a micro-cap name that has seen sharp swings throughout December. StockAnalysis
22 December 2025
·
ABIVAX (ABVX) Stock Surges on Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Kicks In — News, Forecasts and Outlook (Dec. 22, 2025)

ABIVAX (ABVX) Stock Surges on Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Kicks In — News, Forecasts and Outlook (Dec. 22, 2025)

December 22, 2025 — ABIVAX Société Anonyme is back in the spotlight today, with traders juggling two storylines that can move a biotech stock fast: renewed takeover speculation involving Eli Lilly and Abivax’s addition to the Nasdaq Biotechnology Index, effective before today’s market open. GlobeNewswire+2Investing.com+2
22 December 2025
····
1 … 423 424 425 426 427 … 609
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 94 / 100
#2 STRONG BUY

AerCap

NYSE: AER 92 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 BUY

Chevron

NYSE: CVX 86 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.